胶原化异种骨块联合胶原膜与rhBMP-2用于牙槽嵴增量的组织学初步研究
本研究在六只犬下颌骨创建半鞍状骨缺损,随机采用四种处理:PCBB、PCBB负载BMP-2、PCBB加胶原膜、PCBB加胶原膜负载BMP-2。12周后植入钛种植体,8周后行组织形态计量学评估。结果显示BMP-2未显著改善新骨形成或嵴轮廓维持,但所有PCBB均牢固整合并允许种植体植入。
要点
- BMP-2加入PCBB或胶原膜未显著提升水平嵴增量的新骨形成与轮廓维持。
- PCBB无论是否联合胶原膜均表现出明显的骨长入和维持增量嵴轮廓的能力。
- 所有先前增量区域内的种植体均成功骨整合并实现颊侧硬组织完全覆盖。
核心结论
- 在水平嵴增量中,向PCBB或胶原膜添加BMP-2未在增量嵴轮廓维持和新骨形成方面产生统计学显著改善。
- PCBB联合或不联合胶原膜均表现出明显的骨长入和维持增量嵴轮廓的能力,所有增量区域种植体成功骨整合并完全硬组织覆盖。
研究设计与样本
- 本研究为在六只犬下颌骨每侧创建两个半鞍状骨缺损的初步组织学研究。
- 缺损随机分配至四组:PCBB、PCBB负载BMP-2、PCBB加胶原膜、PCBB加胶原膜负载BMP-2;12周后每部位植入一枚钛种植体,8周后制备组织学切片评估。
主要发现
- 增量面积(AA)在PCBB组为10.4 ± 4.2 mm2,PCBB-BMP2组为11.8 ± 2.8 mm2,PCBB + CM组为9.8 ± 2.9 mm2,PCBB + CM-BMP2组为8.5 ± 2.2 mm2;仅PCBB-BMP2与PCBB + CM-BMP2之间差异有统计学意义(P = 0.031)。
- 新骨面积(NB)在PCBB组为2.3 ± 1.3 mm2,PCBB-BMP2组为2 ± 0.5 mm2,PCBB + CM组为2.7 ± 1.2 mm2,PCBB + CM-BMP2组为1.8 ± 0.7 mm2;各组间无统计学显著差异。
- 新骨及残余骨替代材料的最冠方和最颊侧位置以及骨-种植体接触在组间均无统计学显著差异(P > 0.05)。
临床怎么用
- 对于水平牙槽嵴增量,PCBB单独或联合胶原膜可维持增量轮廓并支持种植体骨整合。
- 添加BMP-2未显示额外获益,临床决策时应权衡成本与收益。
局限性
- 本研究为犬类初步组织学研究,样本量小(六只犬),结果需谨慎外推至临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this pilot study was to test whether a porcine collagenated bone substitute block (PCBB) and collagen membrane (CM) loaded with bone morphogenetic protein-2 (BMP-2) used for horizontal ridge augmentation differ from PCBB and CM without BMP-2 regarding the osseointegration of the grafting material and the maintenance of the ridge contour. MATERIAL AND METHODS: Two semi-saddle bone defects were created in each side of the mandible of six dogs. The defects were randomly allocated to receive one of the following treatments: bone augmentation using (1) PCBB, (2) PCBB loaded with BMP-2 (PCBB-BMP2), (3) PCBB + CM and (4) PCBB + CM loaded with BMP-2 (PCBB + CM-BMP2). After 12 weeks, one titanium implant was inserted into every site. After 8 weeks, one central histological section of each site was prepared. Histomorphometrical assessments were performed evaluating the augmented area (AA), the area of new bone (NB) (primary outcome), residual bone substitute (BS) and non-mineralized tissue (NMT) within AA in mm2 . In addition, the most coronal and the most buccal localizations of new bone and residual bone substitute, and the most coronal bone-to-implant contact were measured in mm. RESULTS: Clinically, all PCBB were firmly integrated and permitted implant placement. All the implants osseointegrated and exhibited complete hard-tissue coverage of the buccal surface. Bone ingrowth always reached the central portions of PCBB. AA measured 10.4 ± 4.2 mm2 for PCBB, 11.8 ± 2.8 mm2 for PCBB-BMP2, 9.8 ± 2.9 mm2 for PCBB + CM and 8.5 ± 2.2 mm2 for PCBB + CM-BMP2. Only the difference between PCBB-BMP2 and PCBB + CM-BMP2 was statistically significant (P = 0.031). NB reached 2.3 ± 1.3 mm2 for PCBB, 2 ± 0.5 mm2 for PCBB-BMP2, 2.7 ± 1.2 mm2 for PCBB + CM and 1.8 ± 0.7 mm2 for PCBB + CM-BMP2. There were no statistically significant differences regarding NB, the most coronal and the most buccal localizations of new bone, residual bone substitute and bone-to-implant contact (P > 0.05). CONCLUSIONS: The addition of BMP-2 to PCBB or CM used for horizontal ridge augmentation did not render a statistically significant improvement in the maintenance of the augmented ridge contour and the new bone formation. PCBB with and without CM showed pronounced bone ingrowth and capacity to maintain the augmented ridge contour. In all the regions previously augmented with PCBB, the implants successfully integrated and presented with complete hard-tissue coverage.
引用
- Benic GI, Joo MJ, Yoon SR, et al. Primary ridge augmentation with collagenated xenogenic block bone substitute in combination with collagen membrane and rhBMP-2: a pilot histological investigation. Clin Oral Implants Res. 2017. PMID: 28574217. doi:10.1111/clr.13024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。